Company news
Sangamo Therapeutics, Inc. news in 2020
Sangamo Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x10¹³ VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy
December 6, 2020
Sangamo Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results
November 3, 2020
Sangamo Therapeutics Announces Third Quarter 2020 Conference Call and Webcast
October 27, 2020
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
October 6, 2020
Sangamo Therapeutics Appoints Kenneth Hillan to Its Board of Directors
September 10, 2020
Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference
August 9, 2020
Sangamo Therapeutics Reports Business Highlights and Second Quarter 2020 Financial Results
August 4, 2020
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders
July 29, 2020
Sangamo Therapeutics Announces Second Quarter 2020 Conference Call and Webcast
July 28, 2020
Sangamo Announces R&D Organization Changes
June 23, 2020
Sangamo Therapeutics Announces Participation at the Jefferies Virtual Healthcare Conference
May 28, 2020
Sangamo Therapeutics Announces Participation at the Bank of America 2020 Health Care Conference
May 11, 2020
Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial Results
May 10, 2020
Sangamo Therapeutics Announces Virtual Format for 2020 Annual Meeting
May 6, 2020
Sangamo Therapeutics Announces First Quarter 2020 Conference Call and Webcast
May 3, 2020
Sangamo Therapeutics Announces Presentations at 2020 Annual Meeting of the American Society of Gene & Cell Therapy
April 27, 2020
Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells
April 20, 2020
Sangamo Appoints D. Mark McClung as Executive Vice President and Chief Business Officer
April 16, 2020
Sangamo Announces Closing of Biogen Collaboration Agreement
April 8, 2020
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
February 27, 2020
Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
February 26, 2020
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2019 Conference Call and Webcast
February 24, 2020
Sangamo Therapeutics Appoints John Markels to Its Board of Directors
February 11, 2020
Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 8, 2020
Decks in 2020
- World Federation of Hemophilia (WFH) Virtual Summit 2020
Conference · 15 slides · Jun 18, 2020